Skip to main content
FDA approves futibatinib (Lytgobi) for certain biliary tract cancers
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
FDA approves futibatinib (Lytgobi) for certain biliary tract cancers
User login
Username
Password
Reset your password
Concept
Lead
score
Noncolorectal Gastrointestinal Cancer
1
1
Hepatocellular Carcinoma
0
1
Genomic Medicine
0
0.77
Biologic Therapy
0
0.67
Dentistry and Oral Health
0
0.67
Otolaryngology
0
0.63
Cancer
0
0.58
Toxicology
0
0.51
Cholangiocarcinoma
0
1
Biliary Tract
0
1
Precision Medicine
0
0.25
Pain Management
0
0.23
Arthralgia
0
0.2
Abdominal Pain
0
0.19
Grant
0
0.17
Liver
0
0.17
Pain
0
0.17
Tumor
0
0.17
Xerostomia
0
0.12
Alopecia
0
0.09
Constipation
0
0.09
Diarrhea
0
0.09
Dry Eye
0
0.09
Urinary Tract Infection
0
0.09
Abdomen
0
0.08
Bile
0
0.08
DNA Sequencing
0
0.08
Dysgeusia
0
0.08
Fatigue
0
0.08
Fibroblast Growth Factor
0
0.08
Hospital
0
0.08
Massachusetts
0
0.08
Mouth
0
0.08
Nail
0
0.08
Nausea
0
0.08
Orbit
0
0.08
Palmar
0
0.08
Plantar
0
0.08
Receptors
0
0.08
Stomatitis
0
0.08
Xeroderma
0
0.08
Specialty
Lead
score
Hematology-Oncology
1
1
Gastroenterology
0
1
Emergency Medicine
0
0.58
Ophthalmology
0
0.51
Dental & Oral Health
0
0.25
Rheumatology
0
0.25
Hospital Medicine
0
0.09
Edit Tags